BIOTECH TARGET N V
SEC CIK 1259870 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MGNX | MACROGENICS INC | 10% | 9.78M | $7.33M | — | 4 | 2021-11-19 | 2023-09-07 |
Most active insiders at MGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Peters Jeffrey Stuart | GC, Senior VP, Sec | — | $129.1K |
| 2 | Smith Beth Ann | VP, Ctrl, Treas | — | — |
| 3 | SIEGEL JAY PHILIP | Dir | — | — |
| 4 | Spitznagel Thomas | SVP, Technical Ops | — | — |
| 5 | Ferrante Karen Jean | Dir | — | — |
| 6 | Bonvini Ezio | SVP, CSO, Research | — | — |
| 7 | Risser Eric Blasius | Pres, CEO, Dir | — | — |
| 8 | Koenig Scott | Dir | — | — |
| 9 | Karrels James | SVP, CFO | — | — |
| 10 | Jackson Scott Thomas | Dir | — | — |
BIOTECH TARGET N V made no open-market trades at MGNX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-11 | 2023-09-07 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% | P - Purchase | $5.26 | +200.0K | 9.78M | +2% | +$1.05M | |
| 2023-01-23 | 2023-01-19 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% | P - Purchase | $5.30 | +150.0K | 9.08M | +2% | +$795.0K | |
| 2022-11-25 | 2022-11-22 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% | P - Purchase | $5.96 | +300.0K | 8.53M | +4% | +$1.79M | |
| 2021-11-23 | 2021-11-19 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% | P - Purchase | $18.50 | +200.0K | 7.28M | +3% | +$3.70M |
Purchase Sale Sale after option exercise All abbreviations